BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Titan Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524717
ISIN Demat
INE150C01029
Book Value (Rs)
41.3474594
NSE Symbol
N.A
Divident Yield %
0.12
Market Cap
(Rs In Cr.)
1,681
P/E (TTM)
54.69
EPS (TTM)
7.44
Face Value
(Rs)
2
Back
Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter
02-Jun-26   Hrs IST

Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales48.8335.17 39 206.19156.45 32
OPM %19.8912.99 -18.7216.25 -
PBDT11.585.87 97 43.1028.54 51
PBT10.285.03 104 38.1724.37 57
NP6.734.05 66 29.8921.53 39

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)